Cargando...
Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102)
Trifluridine/tipiracil (TAS-102) is a new oral combination therapy approved by the US Food and Drug Administration for the treatment of patients with metastatic colorectal cancer who are refractory to or intolerant of standard chemotherapy. This agent consists of a thymidine-based nucleoside analog...
Gardado en:
| Publicado en: | Clin Colorectal Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5743195/ https://ncbi.nlm.nih.gov/pubmed/28242161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2017.01.003 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|